Harbourvest Partners’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Harbourvest Partners’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-48,835	Closed	-$14.6K	–	62
2023 Q2	$14.6K	Hold	48,835	–	–	﹤0.01%	60
2023 Q1	$21.1K	Hold	48,835	–	–	0.01%	61
2022 Q4	$57.6K	Hold	48,835	–	–	0.02%	62
2022 Q3	$113K	Buy	+48,835	New	+$128K	0.04%	64

Harbourvest Partners's GRNA Position: Q3 2023 in Review

Harbourvest Partners sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 48,835 shares — an estimated $14.6K sold.

Harbourvest Partners first reported a position in GRNA in Q3 2022 and held it in 4 quarters. The position peaked at $113K in Q3 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Harbourvest Partners reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Harbourvest Partners sold 48,835 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $14.6K.
Harbourvest Partners first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q3 2022 and held it in 4 quarters.
Harbourvest Partners's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $113K in Q3 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Harbourvest Partners's 13F filing for Q3 2023, filed 14 Nov 2023.